Polymorphisms in DNA repair genes and breast cancer risk in Russian population: a case-control study. 2016

Alexandra S Shadrina, and Natalia A Ermolenko, and Uljana A Boyarskikh, and Tatiana V Sinkina, and Alexandr F Lazarev, and Valentina D Petrova, and Maxim L Filipenko
Institute of Chemical Biology and Fundamental Medicine, Lavrentjeva, 8, 630090, Novosibirsk, Russia. weiner.alexserg@gmail.com.

Genetic variation in DNA repair genes can alter an individual's capacity to repair damaged DNA and influence the risk of cancer. We tested seven polymorphisms in DNA repair genes XRCC1, ERCC2, XRCC3, XRCC2, EXOI and TP53 for a possible association with breast cancer risk in a sample of 672 case and 672 control Russian women. An association was observed for allele A of the polymorphism XRCC1 (R399Q) rs25487 (co-dominant model AA vs. GG: OR 1.76, P = 0.003; additive model OR 1.28, P = 0.005; dominant model: OR 1.29, P = 0.03; recessive model OR 1.63, P = 0.008). Allele T of the polymorphism ERCC2 (D312N) rs1799793 was also associated with breast cancer risk (co-dominant model TT vs. CC: OR 1.43, P = 0.04; additive model OR 1.21, P = 0.02; dominant model: OR 1.30, P = 0.02), but the association became insignificant after applying Bonferroni correction. No association with breast cancer was found for the remaining SNPs. In summary, our study provides evidence that polymorphisms in DNA repair genes may play a role in susceptibility to breast cancer in the population of ethnical Russians.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D004260 DNA Repair The removal of DNA LESIONS and/or restoration of intact DNA strands without BASE PAIR MISMATCHES, intrastrand or interstrand crosslinks, or discontinuities in the DNA sugar-phosphate backbones. DNA Damage Response
D004268 DNA-Binding Proteins Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. DNA Helix Destabilizing Proteins,DNA-Binding Protein,Single-Stranded DNA Binding Proteins,DNA Binding Protein,DNA Single-Stranded Binding Protein,SS DNA BP,Single-Stranded DNA-Binding Protein,Binding Protein, DNA,DNA Binding Proteins,DNA Single Stranded Binding Protein,DNA-Binding Protein, Single-Stranded,Protein, DNA-Binding,Single Stranded DNA Binding Protein,Single Stranded DNA Binding Proteins
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000076105 X-ray Repair Cross Complementing Protein 1 A poly(ADP)-ribose-binding protein that functions in the rejoining of DNA single-strand breaks that arise following treatment with alkylating agents or ionizing radiation. It interacts with DNA LIGASE III and POLY ADP RIBOSE POLYMERASE in BASE EXCISION REPAIR, and may also function in DNA processing and chromosome recombination in GERM CELLS. XRCC1 DNA Repair Protein,XRCC1 Protein,X ray Repair Cross Complementing Protein 1
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

Alexandra S Shadrina, and Natalia A Ermolenko, and Uljana A Boyarskikh, and Tatiana V Sinkina, and Alexandr F Lazarev, and Valentina D Petrova, and Maxim L Filipenko
February 2012, Oncology letters,
Alexandra S Shadrina, and Natalia A Ermolenko, and Uljana A Boyarskikh, and Tatiana V Sinkina, and Alexandr F Lazarev, and Valentina D Petrova, and Maxim L Filipenko
October 2010, Journal of cancer research and clinical oncology,
Alexandra S Shadrina, and Natalia A Ermolenko, and Uljana A Boyarskikh, and Tatiana V Sinkina, and Alexandr F Lazarev, and Valentina D Petrova, and Maxim L Filipenko
November 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
Alexandra S Shadrina, and Natalia A Ermolenko, and Uljana A Boyarskikh, and Tatiana V Sinkina, and Alexandr F Lazarev, and Valentina D Petrova, and Maxim L Filipenko
May 2014, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
Alexandra S Shadrina, and Natalia A Ermolenko, and Uljana A Boyarskikh, and Tatiana V Sinkina, and Alexandr F Lazarev, and Valentina D Petrova, and Maxim L Filipenko
July 2012, Genetika,
Alexandra S Shadrina, and Natalia A Ermolenko, and Uljana A Boyarskikh, and Tatiana V Sinkina, and Alexandr F Lazarev, and Valentina D Petrova, and Maxim L Filipenko
February 2014, International journal of cancer,
Alexandra S Shadrina, and Natalia A Ermolenko, and Uljana A Boyarskikh, and Tatiana V Sinkina, and Alexandr F Lazarev, and Valentina D Petrova, and Maxim L Filipenko
January 2008, Anticancer research,
Alexandra S Shadrina, and Natalia A Ermolenko, and Uljana A Boyarskikh, and Tatiana V Sinkina, and Alexandr F Lazarev, and Valentina D Petrova, and Maxim L Filipenko
July 2006, Carcinogenesis,
Alexandra S Shadrina, and Natalia A Ermolenko, and Uljana A Boyarskikh, and Tatiana V Sinkina, and Alexandr F Lazarev, and Valentina D Petrova, and Maxim L Filipenko
November 2014, Genetic testing and molecular biomarkers,
Alexandra S Shadrina, and Natalia A Ermolenko, and Uljana A Boyarskikh, and Tatiana V Sinkina, and Alexandr F Lazarev, and Valentina D Petrova, and Maxim L Filipenko
June 2008, Pathology oncology research : POR,
Copied contents to your clipboard!